Metraipolis › archive › dc_6aa9aed9ff8b

Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial — Europe PMC PMID:40434509

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40434509
DOI
10.1007/s10147-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-08T13:26:44.281Z
SHA-256 of the archived text
4da812bcb856bc95a1a81401b9633aa890d36eb67c38b26577e9a1a218b1ad4e
Stable URL of this page
https://metraipolis.com/documento/dc_6aa9aed9ff8b

How to cite

Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial — Europe PMC PMID:40434509 — Europe PMC (en), https://europepmc.org/article/MED/40434509 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6aa9aed9ff8b (Metraipolis archive dc_6aa9aed9ff8b, sha256 4da812bcb856bc95a1a81401b9633aa890d36eb67c38b26577e9a1a218b1ad4e)
BibTeX
@misc{dc6aa9aed9ff8b,
  title = {Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial — Europe PMC PMID:40434509},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40434509},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6aa9aed9ff8b; sha256 4da812bcb856bc95a1a81401b9633aa890d36eb67c38b26577e9a1a218b1ad4e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40434509. Agents can read the archived copy with the MCP tool read_document.